Pranav Abraham

Medical Evidence Strategy Leader, Global Medical Affairs, Rare Diseases

Sanofi

Biography

Pranav Abraham leads Medical Evidence Strategy for Sanofi’s Global Medical Affairs Rare Diseases team. He has deep expertise in using digital health technologies to capture patient outcomes, develop novel endpoints, and leverage healthcare data for generating innovative real-world evidence to inform regulatory, payer, and clinical decision-making. Prior to Sanofi, Pranav headed the global health economics strategy for several oncology and hematology indications at Bristol Myers Squibb. He holds a Ph.D. in Pharmaceutical Economics and Policy from the Massachusetts College of Pharmacy and Health Sciences in Boston and is currently pursuing the MBA For Executives program at Yale SOM.
He is passionate about driving the adoption of digital health technologies, AI/ML techniques, and data analytics in routine clinical practice, along with advising new ventures in this space.